Related Experiment Videos

Rubella-specific IgM in reinfection and risk to the fetus

M Zolti1, Z Ben-Rafael, D Bider

  • 1Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Insights

A vaccinated woman experienced rubella reinfection during early pregnancy. Despite symptoms and high IgM, the fetus showed no signs of infection, suggesting cordocentesis is valuable before pregnancy termination decisions.

Area of Science:

  • Virology
  • Immunology
  • Obstetrics

Background:

  • Rubella infection during pregnancy poses risks to fetal development.
  • Vaccination aims to prevent rubella, but breakthrough infections can occur.
  • Assessing fetal rubella status is crucial for pregnancy management.

Observation:

  • A case of wild rubella virus reinfection in an immunized patient at 8 weeks gestation.
  • The patient presented with clinical symptoms and high-titer rubella-specific immunoglobulin M (IgM).
  • Preexisting low-titer hemagglutination inhibition antibodies were noted post-vaccination.

Findings:

  • Following therapeutic termination of pregnancy, no rubella virus was detected in fetal tissues.
  • Fetal blood samples lacked rubella-specific IgM antibodies.
  • The absence of fetal infection suggests successful containment or lack of transmission.

Implications:

  • Cordocentesis can provide definitive fetal status assessment for rubella.
  • This diagnostic approach aids in informed decisions regarding pregnancy interruption.
  • Further research into rubella reinfection dynamics and fetal outcomes is warranted.

Related Concept Videos